arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

Absci Corp

ABSI
$8.94 ▲ +0.64 (+7.78%) at close
Industrials ·Services-Commercial Physical & Biological Research ·USServices-Commercial Physical & Biological Research
26 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
18
Health
Poor
Bearish
auto_awesome

Analytical Summary

Absci Corp faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $1.4B
Dividend Yield
Revenue Growth -81.8%
Op. Margin None
ROIC -17.9%
FCF / Share $-0.17
Trailing P/E
Price / Book 8.0x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

26-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$215.00K
↓ -81.8%
Net Income Profit after all expenses
$-29.60M
↓ -12.3%
Operating Margin Operating profit as % of sales
-169.8%
↑ +53.8%
FCF / Share Free cash flow per share
$-0.17
↑ +2.0%
Long-Term Debt Long-term obligations
$8.87M
↓ -4.2%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns
14
Financial Health
6
Cash Quality
55

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 26 quarters